K160725 is an FDA 510(k) clearance for the EndoFLIP. Classified as System, Gastrointestinal Motility (electrical) (product code FFX), Class II - Special Controls.
Submitted by Crospon, Ltd. (Galway, IE). The FDA issued a Cleared decision on May 1, 2016 after a review of 46 days - a notably fast clearance cycle.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1725 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.